Your browser doesn't support javascript.
loading
CDK4/6 inhibitors combined with fulvestrant for HR+/HER2- advanced breast cancer.
Zhang, Jie; Hao, Chunfang.
Afiliação
  • Zhang J; Department of Breast Oncology, Tianjin Cancer Hospital Airport Hospital, Tianjin, China.
  • Hao C; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Cancer Hospital Airport Hospital, Tianjin, China.
Transl Breast Cancer Res ; 3: 10, 2022.
Article em En | MEDLINE | ID: mdl-38751525
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Transl Breast Cancer Res Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Transl Breast Cancer Res Ano de publicação: 2022 Tipo de documento: Article